CLINICAL CASE OF HEMORRHAGIC CYSTITIS TREATMENT COMPLICATED BY HEMOTAMPONADE OF THE BLADDER IN A PATIENT IN THE EXTRACORPOREAL PROGRAM FERTILIZATION

Nikiforov O. A., Letsin D. V.

CLINICAL AND EXPERIMENTAL MEDICINE

Scentific article

Aim of the research. Description of a clinical case using the various methods of diagnosis and treatment of hemorrhagic cystitis in the extracorporeal program fertilization. Object and methods of research. A 29-year-old patient К. presented with hemorrhagic cystitis complicated by bladder hemotamponade, which was a result of in vitro fertilization. For the purpose of investigation and monitoring of the patient condition complete blood count, basic metabolic panel, urine test and ultrasonography of the abdomen and the cystoscopy were performed. Management was based on the current Ukrainian medical guidelines. Research results and discussion. After a thorough investigation of this clinical case, we can say that the patient had hemorrhagic cystitis complicated by hemotamponade of the bladder as a result of in vitro fertilization. Each individual patient should have an individual approach when choosing protocols for medical ovarian stimulation in an in vitro fertilization program. Conclusions. When using assisted reproductive technologies in patients in the in vitro fertilization program, complications may occur during and after transvaginal follicle puncture. Transvaginal puncture of the follicles carries the risk of bleeding, damage to the bladder, intestines or blood vessels. To date, a large number of clinical studies have been conducted in the in vitro fertilization program in order to ensure the safety of these procedures and with minimal risk to the patient. The variety of diseases manifested by hematuria, the features of the development and clinical course of these pathological processes require an integrated approach based on a multidisciplinary approach in the field of therapy, urology, gynecology, oncology and infectious pathology. The choice of protocol for medical ovarian stimulation should be based on individual approach, taking into account the degree of risk of any complication.

hematuria, hemorrhagic cystitis, bladder tamponade, in vitro fertilization, cystoscopy

1. Vdovychenko SYu. Rodynno-oriientovani tekhnolohii u zhinok iz bezpliddiam v anamnezi. Reproduktyvnoe zdorove zhenshchyny. 2020;3:21-23. [in Ukrainian].
2. Strelko HV. Medyko-sotsialni kharakterystyky zhinok zi znyzhenoiu vidpoviddiu na stymuliatsiiu u prohrami ekstrakorporalnoho zaplidnennia. Simeina medytsyna. 2019;5.6:157-161. [in Ukrainian].
3. Dykusarova SM. Perynatalni vyslidy bahatoplidnoi vahitnosti pislia zaplidnennia in vitro ta pry spontannykh vahitnostiakh. Perynatolohyia y pedyatryia. 2018;1:70-73. [in Ukrainian].
4. Tumanova LYe. Osoblyvosti perebihu vahitnosti u zhinok z bezplidnistiu endokrynnoho ta zapalnoho genezu v anamnezi zalezhno vid sposobu zaplidnennia. Perynatolohyia y pedyatryia. 2019;1:30-35. [in Ukrainian].
5. Nakonechna AV. Stan emotsiinoi sfery zhinok iz bezpliddiam pry povtornomu zastosuvanni protokolu ekstrakorporalnoho zaplidnennia. Ukrainskyi medychnyi chasopys. 2018;6:38-39. [in Ukrainian].
6. Holovatiuk KP. Rivni interleikinu-4 ta interleikinu-17 (IL-4, IL-17) krovi u patsiientok zi zvychnym nevynoshuvanniam vahitnosti, yaka nastala u tsykli ekstrakorporalnoho zaplidnennia. Zdorovia zhinky. 2016;8:137-139. [in Ukrainian].
7. Kotsabyn NV. Osoblyvosti ekspresii yadernykh steroidnykh retseptoriv v endometrii u zhinok z nevdalymy sprobamy zaplidnennia in vitro v anamnezi. Zdorovia zhinky. 2016;9:155-158. [in Ukrainian].
8. Strelko HV. Klinichne znachennia khronichnoho endometrytu u zhinok zi znyzhenoiu vidpoviddiu na stymuliatsiiu yaiechnykiv u prohrami ekstrakorporalnoho zaplidnannia. Zdorovia zhinky. 2018;4:92-97. [in Ukrainian].
9. Aiziatulova EM. Suchasnyi pidkhid shchodo provedennia kontrolovanoi stymuliatsii yaiechnykiv u tsyklakh dopomizhnykh reproduktyvnykh tekhnolohii u zhinok iz vysokym ryzykom syndromu hiperstymuliatsii yaiechnykiv. Aktualni pytannia pediatrii, akusherstva ta hinekolohii. 2016;1:34-36. [in Ukrainian].
10. Ziuzykova ZS. Sostoianye zdorovia detei, rozhdennykh v rezultate prymenenyia vspomohatelnykh reproduktyvnykh tekhnolohyi: pozytsyia эndokrynoloha. Problemy endokrynolohyy. 2018;4:235-243. [in Russian].
11. Zhukovskaia SV. Yssledovanye systemy hemostaza pry razvytyy syndroma hyperstymuliatsyy yaychnykov u zhenshchyn, vkliuchennykh v prohrammy vspomohatelnykh reproduktyvnykh tekhnolohyi. Reproduktyvnoe zdorove. Vostochnaia Evropa. 2019;4:486-497.
12. Mozheiko LF. Prymenenye metformyna v prohrammakh vspomohatelnykh reproduktyvnykh tekhnolohyi u patsyentok s syndromom polykystoznykh yaychnykov. Reproduktyvnoe zdorove. Vostochnaia Evropa. 2019;2:234-241. [in Ukrainian].
13. Borys EN, Kamynskyi AV, Sumenko VV, Onyshchyk LN, Serbeniuk AV. Sravnytelnaia otsenka эffektyvnosty prymenenyia mykronyzyrovannoho prohesterona peroralno, yntravahynalno y sublynhvalno v tsyklakh vspomohatelnykh reproduktyvnykh tekhnolohyi y v I trymestre nastupyvshykh beremennostei. Zdorovia zhinky. 2015;3:162-168. [in Ukrainian].
14. Shutov SA. Opyt prymenenyia rekombynantnoho aktyvyrovannoho faktora VII v lechenyy hemorrahycheskoho tsystyta u patsyenta s эkstranodalnoi lymfomoi. Voprosy hematolohyy, onkolohyy y ymmunopatolohyy v pedyatryy. 2012;2:1-4. [in Russian].
15. Prozorov SA, Tarabaryn SA, Kondratova NV, Mkrtchian KH. Prymenenye эmbolyzatsyy pry krovotechenyy u bolnykh s opukholiamy mochevoho puzyria. Sklifosovsky Journal of Emergency Medical Care. 2017;4:358-362. [in Russian].
16. Safronova OV. Alhorytm pidhotovky ta provedennia vysokotekhnolohichnoi dystantsiinoi promenevoi terapii pry likuvanni patsiientiv, khvorykh na rak peredmikhurovoi zalozy. Zdorovia Ukrainy. 2016;2:46-47. [in Ukrainian].
17. Tytov EV. Prohnostycheskye markery retsydyvyrovanyia y prohressyy neynvazyvnoho urotelyalnoho raka mochevoho puzyria. Ukrainskyi radiolohichnyi zhurnal. 2019;3:193-197. [in Ukrainian].
18. Saidakova NO. Characteristics of the incidence and prevalence of chronic cystitis among the male population in Ukraine. Zdorovia cholovika. 2021;2:21-25. [in Ukrainian].
19. Szymanska B. Evaluation of NMP22 in bladder cancer patients sensitive to environmental toxins. Advances in clinical and experimental medicine. 2017;26(7):1069-1075.
20. Kosaka T. Hemorrhagic cystitis in a patient without a past history of radiation therapy who was treated with cabazitaxel for CRPC. Annals of Oncology. 2015;26(11):2355-2356.
21. Loffroy R, Pottecher P, Cherblanc V, Favelier S, Estivalet L, Koutlidis N, et al. Current role of transcatheter arterial embolization for bladder and prostate hemorrhagе. Diagn Interv Imaging. 2014; 95(11):1027-1034.

«Bulletin of problems biology and medicine» Issue 1 (163), 2022 year, 146-150 pages, index UDK 618.177-089.888.11-06:616.62-018.73-002-06

10.29254/2077-4214-2022-1-163-146-150